Risk of peripartum cerebrovascular events in women with moyamoya disease: A multicenter cohort study
- 26 November 2025
- journal article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (8) , 1159-1169
Abstract
Background: Pregnancy and delivery are known to increase the risk of cerebrovascular events (CVEs) in patients with moyamoya disease (MMD). This study determined the frequency, risk factors, and outcome of CVEs during pregnancy in MMD. Methods: We conducted a multicenter study involving 171 MMD patients with 196 deliveries across four Korean tertiary institutions between 1990 and 2023. Data on MMD-related clinical, imaging, and operative findings were collected. We analyzed CVEs and pregnancy outcomes, including delivery mode and anesthesia. Univariate and multivariate analyses were performed to identify risk factors for peripartum CVEs. Results: Peripartum CVEs occurred in 5.6% of pregnancies, with intracerebral hemorrhage being the most common, followed by cerebral infarction. CVEs were more common in women diagnosed with MMD during pregnancy (85.7% vs. 2.6% in women diagnosed before pregnancy) and in women who had not completed revascularization before pregnancy or were hemodynamically unstable: 55.6% versus 1.1%. Delivery mode and anesthesia showed no significant association with the occurrence of CVEs. Multivariate analysis revealed that the “non-revascularized or hemodynamically unstable” group remained a significant risk factor for peripartum CVEs (adjusted odds ratio (OR) = 353.23, P < 0.001). CVEs resulted in maternal functional impairment in 4 of 11 affected cases (36.4%) and fetal loss in 2 of 11 cases (18.2%). Conclusion: This study highlights the protective effect of revascularization on peripartum CVEs and proposes a structured clinical protocol, recommending prepregnancy hemodynamic assessment and neurosurgical consultation. Women diagnosed with MMD during pregnancy and those in the “non-revascularized or hemodynamically unstable” group should be considered a high-risk group for peripartum CVEs.Keywords
Funding Information
- National Institute on Drug Abuse (23C-027-0100)
This publication has 32 references indexed in Scilit:
- Maternal hemodynamic profile during pregnancy and in the post-partum in hypertensive disorders of pregnancy and fetal growth restrictionAmerican Journal of Obstetrics & Gynecology MFM, 2022
- Hypertensive disorders and maternal hemodynamic changes in pregnancy: monitoring by USCOM® deviceJournal of Medical Ultrasonics, 2022
- Pregnancy outcomes in women with dilated cardiomyopathy: Peripartum cardiovascular events predict post delivery prognosisJournal of Cardiology, 2021
- Moyamoya Disease in Pregnancy: A 20-Year Single-Center Experience and Literature ReviewWorld Neurosurgery, 2019
- Moyamoya disease in pregnancy: a systematic reviewActa Neurochirurgica, 2018
- Neurologic Deterioration in Patients with Moyamoya Disease during Pregnancy, Delivery, and PuerperiumWorld Neurosurgery, 2018
- Pregnancy and delivery in moyamoya vasculopathy: experience of a single European institutionNeurosurgical Review, 2017
- Physiologic Changes During Normal Pregnancy and DeliveryCardiology Clinics, 2012
- Moyamoya: Epidemiology, Presentation, and DiagnosisNeurosurgery Clinics of North America, 2010
- Pediatric moyamoya disease: An analysis of 410 consecutive casesAnnals of Neurology, 2010